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Abstract
Purpose: Previous clinical studies have suggested a posi-
tive effect of low-frequency pulsed electromagnetic
fields (PEMF) on wound healing and inflammation in the
eye. We tried to test the value of PEMF treatment in a
hyphema animal model with well-defined conditions.
Methods: After injection of citrated autologous blood for
the production of hyphema, 16 rabbit eyes were treated
with 10 or 20 mT for 60 min on 4 days within the postop-
erative week. Two control groups with hyphema alone
(n = 8) and PEMF irradiation without hyphema (n = 4)
were also included. The rate of resorption was recorded
daily. Histopathologic evaluation was performed. Re-
sults: The incidence of endothelial cell damage and
fibrotic clots was markedly reduced in the 10-mT group
while the resorption time of 8 days was identical with the
control group. In the 20-mT group, the complication rate
and the resorption time was increased versus the control
group. Conclusions: The use of PEMF treatment is of
some, however, limited value as it did not reduce the
resorption time of hyphema but displayed a dose-depen-
dent, beneficial influence on some serious side effects.
Future clinical studies with low-dose PEMF irradiation
are justified and should determine the optimal dosage
and suitable indications of PEMFs as an adjunctive treat-
ment in ocular inflammation or trauma. 
Copyright © 2003 S. Karger AG, Basel
Introduction
In previous mostly clinical studies, it has been shown
that so-called low-frequency pulsed electromagnetic fields
(= PEMF) have a beneficial effect in wound healing,
resorption of inflammatory edema or bleeds in various
organs by stimulating metabolic processes, blood circula-
tion and activating cell proliferation. The exact mecha-
nisms for the biological effects of PEMF are not yet
understood. In vitro studies have demonstrated effects of
PEMF on ion transport across cell membranes, DNA syn-
thesis, RNA transcription and cell division rate [1]. Wide-
spread use of PEMF is common in orthopedics where suc-
cessful application of PEMF has been reported for exam-
ple in the treatment of delayed or non-union bone frac-
tures [2], osteoarthritis or osteoporosis [3]. Moreover,
PEMF have been used for the treatment of nerve lesions
[4] and in chronic skin wound healing [5] like in venous
leg ulcers.
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Fig. 1. a Right rabbit eye on the day of injec-
tion with total hyphema (left) and with
aqueous blood level and 20% hyphema
(right) 5 days after intracameral blood injec-
tion (10 mT group). b PEMF generator with
anesthetized rabbit under the application
head and monitoring unit.
In the eye, the successful use of PEMF has been
reported in corneal wound healing [6], dry eye syndrome,
acute keratoconus [7], glaucoma [8], endocrine ophthal-
mopathy [9] and various optic nerve lesions [10]. Most of
these studies come from the former Soviet Union and are
still controversial or even unknown in Western countries.
Therefore, we have conducted an experimental study
to test the effect of PEMF in the eye under well-defined
conditions using the hyphema model in rabbits allowing
unequivocal quantitative measurements of treatment ef-
fects like the rate of hyphema resorption that can be easily
assessed because of the transparency of the cornea [11]
and evaluation of complications by clinical observation
and histopathological examination.
Materials and Methods
Treatment Groups
28 female New Zealand White rabbits (2–3 kg) were divided into
four groups:
A The low-dose group (n = 8) with hyphema was exposed to PEMF
(10 mT, 50 Hz, 50 T/s, 60 min) on days 1, 2, 3 and 6 postopera-
tively.
B The high-dose group (n = 8) with hyphema was exposed to PEMF
( 20 mT, 200 Hz, 450 T/s, 60 min) on days 1, 2, 3 and 6 postoper-
atively.
C A non-irradiated control group (n = 8) with hyphema, sham anes-
thesia and spontaneous resorption to find the spontaneous re-
sorption rate and exclude side effects due to hyphema.
D A control group (n = 4) without hyphema but high-dose PEMF
treatment (20 mT, 200 Hz, 450 T/s, 60 min) on days 1, 2, 3 and 6
postoperatively to exclude side effects due to irradiation alone.
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Fig. 2. a Chamber angle with fibrotic blood
clot (= C) after 20 mT treatment. HE. !400.
b High-power view of same eye showing
degenerated endothelial cells with vacuoles
(arrow). HE. !1,000 (oil immersion).
Experimental Hyphema
For premedication, 1.5 ml ketamine hydrochloride 10% and
0.5 ml xylazine hydrochloride were given subcutaneously. Anesthe-
sia was achieved with subcutaneous injection of a mixture of diaze-
pam and atropine. Whole blood was drawn from the ear vein using a
1-ml tuberculin syringe containing 0.05 ml of 3.8% sodium citrate.
After instillation of 0.5% proparacaine hydrochloride onto the cor-
nea, 300 Ìl of aqueous was removed by an injection needle at the 11
o’clock position and the equivalent of about 300 Ìl citrated whole
blood was injected instead. No suturing of the injection site was nec-
essary. Postoperatively, antibiotic ointment was applied. The rabbits
were checked the next day and only the eyes with at least 55–60% of
hyphema were utilized for the experiment. As the citrated blood
gravitated inferiorly with a horizontal aqueous-blood fluid level, the
hyphema volume could be estimated as a percentage of the anterior
chamber volume (fig. 1a) sometimes supported by transillumination
using a pen light. A rough estimation of increased intraocular pres-
sure was made by palpation because tonometry could not be used due
to corneal edema. The animals were sacrificed using an overdose of
trepanal intravenously when the residual hyphema volume was equal
to 5% of the anterior chamber volume. The animals were handled
according to international ethical standards.
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Table 1. Complications (%)
Complications Hyphema alone 10 mT + hyphema 20 mT + hyphema
Endothelial vacuoles 87.5 60 7 85.7
Fibrotic clots 12.5 0 7 32.6 &
Corneal edema 37.5 40 42.9
Glaucoma 25 20 22.2
Corneal neovascularization 37.5 40 71.4 &
Iron deposition 75 80 100 &
Retroc. membrane 25 20 28.8
No complications were observed in the group with irradiation alone.
Fig. 3. Resorption rate over time. x-axis = Percentage of hyphema
volume remaining in anterior chamber (mean B SD). y-axis = Time
after treatment in days.
PEMF Treatment
For each treatment the rabbits had to be anesthetized. The appa-
ratus used (Schüller-Magnetik, Dortmund, Germany) was especially
designed containing a 1.8 ! 28 cm ring-shaped solenoid electromag-
net with a 2-cm open gap for the rabbit eye (fig. 1b). Using a separate
monitoring unit, magnetic field parameters like amplitude, pulse fre-
quency, impulse steepness and treatment time could be regulated
and monitored (fig. 1b). The cornea was protected with gel during the
irradiation.
Histological Evaluation of Complications
The eyes were enucleated and fixed in 4% neutral-buffered for-
malin. The fixed globes were cut in half in a line traversing vertically
the residual hyphema and embedded in paraffin. For each case, five
4-Ìm-thick paraffin sections were stained with hematoxylin-eosin
and Prussian blue. Histopathologic evaluation was performed at var-
ious magnifications using a Zeiss axiomat light microscope (fig. 2).
Results
Average Time of Hyphema Resorption
The average time of resorption (fig. 3) was 7.75 B 1.75
days in the untreated hyphema group, 8.29 B 1.98 days in
the 10-mT group, and 12.43 B 4.43 days in the 20-mT
group. Using analysis of variance (ANOVA) a signifi-
cance level of 0.04 was calculated. Student's t test showed
a significant difference in the resorption time between the
hyphema control group and the 20-mT group (p = 0.016)
and between the 10- and 20-mT groups (p = 0.043). There
was no statistically significant difference between the con-
trol and the 10-mT groups (p = 0.587).
Complications and Histology
Remarkably, the incidence of degenerated endothelial
cells with vacuoles and fibrotic transformation of blood
clots was lower in the 10-mT group vs. the control group.
In the 20-mT group, the incidence of corneal neovascular-
ization, iron deposition and fibrotic clots was higher vs.
the hyphema group (table 1; fig. 2a, b). Iron deposition
was found preferably in the trabecular meshwork, retro-
corneal membranes and in remnants of the hyphema. No
hematocornea was observed. The lens and retina were
unremarkable. There were no side effects in the animals
treated only with 20 mT without hyphema.
Discussion
Our experiments have demonstrated a moderate value
of PEMF treatment in the eye. The complication rate was
lower in the low-dose group with respect to the frequency
of degenerated endothelial cells with vacuoles and of
fibrotic clots while the rate of blood resorption of about 8
days was the same in both the low-dose and the control
group and is in the time range of previous reports [11, 12].
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In the 20-mT group, the complication rate was higher as
for corneal neovascularization, iron deposition and clot
fibrosis probably due to the prolonged resorption time
which was significantly delayed to about 12 days suggest-
ing a dose-dependent effect when compared with the 10-
mT group.
The histological changes observed are important for
the risk of the development of the most severe complica-
tions of hyphema because hematocornea occurs prefera-
bly if either the IOP is increased or endothelial degenera-
tion is present and secondary glaucoma is mostly due to
angle closure by fibrotic clots with anterior synechias [12].
In our study, hematocornea itself was not found probably
due to the relatively rapid drainage of the bulk of the
erythrocytes via the trabecular meshwork and episcleral
veins [13] because of the paucity of fibrin formation due
to anticoagulation [14]. Others were able to produce
hematocornea in rabbits maintaining total hyphema by
repeated injections for a time interval of at least 5 days
[15].
Both the results for the resorption time and the compli-
cation rate point out the importance of the optimal dosage
of PEMF being applied and demonstrate that with too
strong a dosage even harmful effects might occur. In the
literature, a wide range of different doses has been
reported. A typical dosage for a therapeutic application in
ophthalmology is 9 mT, 50 Hz, 20T/s, 7 ! 10 min [8] as
has been used in the low-dose group. In other fields, only
0.3 mT with 2 Hz has been applied for nerve lesions [4] or
high doses like 20 mT with 50 Hz for skin wounds [5].
In conclusion, we think that our experiments have
shown a limited but significant value of PEMF treatment
in eye trauma and we think that PEMF treatment is well
worth being tested as an adjunct treatment in ocular trau-
ma or inflammation in clinical trials. However, future
clinical and experimental studies must cautiously deter-
mine the optimal dosage, establish suitable clinical indi-
cations like vitreous hemorrhage, uveitis, optic neuritis,
etc. and exclude long-term side effects like cataract forma-
tion or disturbances of the blood-retina barrier.
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